USPTO told to avoid negative focus on patent thickets

28-02-2023

Muireann Bolger

USPTO told to avoid negative focus on patent thickets

Michael Vi / Shutterstock.com

Pharma trade body highlighted negative narratives involving continuation patents | Such IP “essential for ongoing research and development” | USPTO requested comments following criticism of patent thickets.


Pharmaceutical Research and Manufacturers of America, USPTO, FDA, patent thickets

LSIPR